Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling dysregulated lncRNAs and networks in non-syndromic cleft lip with or without cleft palate pathogenesis. | Sci Rep | 2024 | 38200098 | PubTator, text mining | PubMed |
| High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients. | PLoS One | 2024 | 38198467 | PubTator, text mining | PubMed |
| Vaccines: a promising therapy for myelodysplastic syndrome. | J Hematol Oncol | 2024 | 38191498 | PubTator, text mining | PubMed |
| Integrative genotyping of cancer and immune phenotypes by long-read sequencing. | Nat Commun | 2024 | 38167262 | PubTator, text mining | PubMed |
| Function and mechanism of GBP1 in the development and progression of cervical cancer. | J Transl Med | 2024 | 38167153 | PubTator, text mining | PubMed |
| Genome-wide kinetic profiling of pre-mRNA 3' end cleavage. | RNA | 2024 | 38164598 | PubTator, text mining | PubMed |
| The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis. | Cancer Med | 2024 | 38164059 | PubTator, text mining | PubMed |
| Global analysis of binding sites of U2AF1 and ZRSR2 reveals RNA elements required for mutually exclusive splicing by the U2- and U12-type spliceosome. | Nucleic Acids Res | 2024 | 38088204 | PubTator, text mining | PubMed |
| Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. | Histopathology | 2024 | 38084880 | PubTator, text mining | PubMed |
| Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia. | Acta Haematol | 2024 | 38035547 | PubTator, text mining | PubMed |
| The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations. | RNA Biol | 2024 | 38017665 | PubTator, text mining | PubMed |
| Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). | Leukemia | 2024 | 38017103 | PubTator, text mining | PubMed |
| A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization. | Nucleic Acids Res | 2024 | 37994701 | PubTator, text mining | PubMed |
| Research progress of additional pathogenic mutations in chronic neutrophilic leukemia. | Ann Hematol | 2024 | 37993585 | PubTator, text mining | PubMed |
| U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review). | Oncol Rep | 2024 | 37975232 | PubTator, text mining | PubMed |
| R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts. | Cancer Res | 2024 | 37967363 | PubTator, text mining | PubMed |
| Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer. | Clin Cancer Res | 2024 | 37939140 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms. | Leuk Lymphoma | 2024 | 37921062 | PubTator, text mining | PubMed |
| Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3. | Eur J Haematol | 2024 | 37918825 | PubTator, text mining | PubMed |
| Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer. | Ann Lab Med | 2024 | 37903652 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=13